Tiagabine Hydrochloride
NDC 72205-087, Tiagabine Hydrochloride, tablet, from Novadoz Pharmaceuticals LLC.
- Product NDC
- 72205-087
- Status
- Listed
- Labeler
- Novadoz Pharmaceuticals LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214816
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72205-087 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIAGABINE HYDROCHLORIDE16 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72205-087-30 | 72205008730 | 30 TABLET in 1 BOTTLE (72205-087-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7c034fe0-cdac-49e1-8e39-592846ea3bec
Use it
Look up 72205-087 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72205-087 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72205-087. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.